grant

Mechanisms of Methylmercury Induced Neuronal Toxicity

Organization ALBERT EINSTEIN COLLEGE OF MEDICINELocation BRONX, UNITED STATESPosted 1 Mar 1996Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY2025AddressAffectAntioxidantsAutoregulationBehavioralBiologic ModelsBiologicalBiological ModelsBreadC elegansC. elegansC.elegansCNS Nervous SystemCaenorhabditis elegansCalciumCell Communication and SignalingCell SignalingCellular StressCellular Stress ResponseCentral Nervous SystemClassificationConsumptionControlled StudyCoupledDataDegenerative DisorderDevelopmentDoseDysfunctionEnvironmental FactorEnvironmental Risk FactorExposure toFaeroe IslandsFaroe IslandsFluorescence Activated Cell Sorting FractionationFluorescence-Activated Cell SortingFluorescence-Activated Cell SortingsFunctional disorderGene Expression MonitoringGene Expression Pattern AnalysisGene Expression ProfilingGeneralized GrowthGeneticGenetic DiversityGenetic VariationGlutamatesGoalsGrowthHomeostasisHumanHuman GeneticsImpairmentIncidenceIndividualInduced pluripotent stem cell derived neuronsIntracellular Communication and SignalingIraqL-GlutamateMetabolicMethyl Mercury CompoundsMethylmercury CompoundsModel SystemModelingModern ManMolecularMolecular TargetMorbidityMorbidity - disease rateNamesNerve CellsNerve UnitNervous System InjuriesNervous System PhysiologyNervous System TraumaNervous System damageNeural CellNeuraxisNeurocyteNeurologic ModelsNeurologic SignsNeurologic functionNeurological DamageNeurological InjuryNeurological ModelsNeurological functionNeurological traumaNeuron from iPSCNeuron from induced pluripotent stem cellsNeuronsNeurotoxinsNew ZealandOutcomeOutcome MeasureOxidation-ReductionOxidative StressPathologicPathway interactionsPatientsPatternPhysiological HomeostasisPhysiopathologyPredispositionProcessProteinsQuality ControlR-Series Research ProjectsR01 MechanismR01 ProgramRNA SeqRNA sequencingRNAseqRedoxResearchResearch GrantsResearch Project GrantsResearch ProjectsResearch ResourcesResourcesRoleSeveritiesSeychellesSignal TransductionSignal Transduction SystemsSignalingSusceptibilitySymptomsSynapsesSynapticSystemSystematicsTestingTherapeuticTissue GrowthToxic effectToxicitiesToxicologyTranscript Expression AnalysesTranscript Expression AnalysisWorkadverse consequenceadverse outcomeanalyze gene expressionbehavior outcomebehavioral outcomebiologicbiological signal transductioncell stressdegenerative conditiondegenerative diseasedesigndesigningdevelopmentaldevelopmental diseasedevelopmental disorderenvironmental riskexperimentexperimental researchexperimental studyexperimentsexposed human populationgene expression analysisgene expression assaygene manipulationgenetic manipulationgenetically manipulategenetically perturbglutamatergichealthy aginghealthy human aginghiPSChuman exposurehuman iPShuman iPSChuman induced pluripotent cellhuman induced pluripotent stem cellshuman inducible pluripotent stem cellshuman inducible stem cellsiPS neuronsiPSC derived-neuronsinduced human pluripotent stem cellsinduced pluripotent stem cell neuronsinnovative technologiesmeasurable outcomemethylmercurymethylmercury exposuremitochondrial dysfunctionnamenamednamingnervous system functionneuralneuron toxicityneuronalneuronal toxicityneurons derived from induced pluripotent stem cellsneurons differentiated from induced pluripotent stem cellsneuroprotectionneuroprotectiveneuropsychiatricneuropsychiatryneurotoxicneurotoxicantneurotoxicityneurotraumanovelontogenyoutcome measurementoxidation reduction reactionpathophysiologypathwaypharmacologicpleiotropic effectpleiotropismpleiotropypreventpreventingprogenitor cell modelprogenitor modelprotein homeostasisproteostasisresponsescRNA sequencingscRNA-seqsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolestem and progenitor cell modelstem cell based modelstem cell derived modelstem cell modelsuccesssynapsetranscriptional profilingtranscriptome sequencingtranscriptomic sequencing
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Methylmercury (MeHg) is a potent neurotoxin affecting both the developing and mature central nervous system

with apparent indiscriminate disruption of multiple homeostatic pathways. However, genetic and environmental

modifiers contribute significant variability to neurotoxicity associated with human exposures. Furthermore,

neurotoxic outcomes show evidence of persistence and latent effects long after exposure has subsided. MeHg

neurotoxicity is associated with oxidative stress and impaired redox homeostasis, mitochondrial dysfunction,

activation of cell stress pathways, alteration of proteostasis, calcium dysregulation, damage to neuronal

processes and neuronal/synaptic dysfunction, to name a few. Though, these same pathological hallmarks are

seen with exposure to many (perhaps even most) neurotoxicants and underlie degenerative and developmental

disorders. Hence, while they serve as key outcomes of MeHg exposure and indicators of neurological damage,

their connection to underlying targets of MeHg neurotoxicity and inter-relationships between each other are

unknown. Compelling evidence identifies both dopaminergic (DAergic) and glutamatergic (GLUergic) neurons

as targets of MeHg-induced persistent neurotoxicity. Here we seek to identify and understand persistent and

latent effects of MeHg toxicity on biological pathways impacted by MeHg toxicity. Our goal is to understand the

toxicological hierarchy and temporal susceptibility of key toxic outcome pathways and their perpetuation. This

proposal leverages innovative technologies and the unique resources of its investigative team to build a highly

translatable and mechanistic approach. The genetically tractable Caenorhabditis elegans (C. elegans) model

system is ideally suited for discovering genetic and molecular mechanisms associated with neurotoxicity. The

human induced pluripotent stem cell (hiPSC) model enables assessment of human genetic/pharmacological

modifiers influencing neurotoxic outcomes and susceptibility along the ontogeny of defined neural lineages. Our

overarching hypothesis is that persistent effects of MeHg are self-perpetuating via interdependent relationships

of key biological pathways that sustain and regulate neurological function. We propose three aims, with each

utilizing C. elegans and hiPSC neuronal models of DAergic and GLUergic neurons, to yield a highly

complementary and robust scientific approach. To address the overarching hypothesis we have designed three

highly meritorious Specific Aims, namely (1) to evaluate the temporal pattern of persistent and latent MeHg

neurotoxicity following early and/or late developmental exposures by unbiased gene expression analysis, (2) to

test the hypothesis that the latency periods and severity of persistent neurotoxic effects of MeHg are dependent

on exposure timing, duration and total levels, and (3) to test the hypothesis that the latent/persistent effects of

MeHg exposure on biological pathways are interrelated and inexorable.

Grant Number: 5R01ES007331-31
NIH Institute/Center: NIH

Principal Investigator: Michael Aschner

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →